Vicki L. Keedy
Vanderbilt University(US)Vanderbilt-Ingram Cancer Center
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Neuroendocrine Tumor Research Advances, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology(2022)1,120 cited
- → Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology(2018)724 cited
- → Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor(2015)575 cited
- → American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy(2011)486 cited
- → First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study(2017)407 cited
- → BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study(2018)324 cited
- → NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021(2020)297 cited
- → Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial(2024)227 cited
- → PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma(2016)202 cited
- → Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial(2013)186 cited